CN Patent

CN114727946A — 药物递送制剂

Assigned to Matheson Ag · Expires 2022-07-08 · 4y expired

What this patent protects

本发明涉及治疗精神疾病和障碍的方法，包括向有需要的受试者施用包含利培酮、三嵌段共聚物和二嵌段共聚物的可注射制剂，其中利培酮的浓度为250‑400mg/mL，并且注射体积为1mL以下。

USPTO Abstract

本发明涉及治疗精神疾病和障碍的方法，包括向有需要的受试者施用包含利培酮、三嵌段共聚物和二嵌段共聚物的可注射制剂，其中利培酮的浓度为250‑400mg/mL，并且注射体积为1mL以下。

Drugs covered by this patent

Patent Metadata

Patent number
CN114727946A
Jurisdiction
CN
Classification
—
Expires
2022-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Matheson Ag
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.